Wealthspire Advisors (Maryland)’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-120
Closed -$2K 2648
2018
Q3
$2K Hold
120
﹤0.01% 2235
2018
Q2
$4K Hold
120
﹤0.01% 1946
2018
Q1
$4K Buy
+120
New +$4K ﹤0.01% 1963